Page 81 - rp-may-2020
P. 81

CPD ACTIVITY  
79 
RET AIL PHARMA C Y • MA Y 2020 
persistent allergic rhinitis (they are only  
first line for intermittent mild allergic  
rhinitis). Antihistamines are particularly  
effective in allergic rhinoconjunctivitis  
and histamine related symptoms such as  
itching, rhinorrhoea, sneezing and eye  
symptoms (Table 1).  They are far less  
27 
effective for nasal congestion.  
First generation oral antihistamines  
(cyproheptadine, dexchlorpheniramine,  
pheniramine, promethazine) may have  
pronounced sedative effects so should  
be avoided in the treatment of allergic  
rhinitis.  The less sedating antihistamines  
28 
can be taken long term with no loss of  
efficacy, and have a good safety profile.   
28 
While all antihistamines are effective,  
non-responders to one antihistamine may  
respond favourably to another. 
29 
Intranasal antihistamines are as effective  
as oral antihistamines, but not as effective  
as INCS.  Onset of action of intranasal  
30 
antihistamine is within 15 minutes, so they  
may be useful in cases of acute onset  
of symptoms. 
22 
Antihistamine-mast cell stabiliser eye  
drops such as ketotifen and olopatadine,  
and antihistamine eye drops including  
azelastine and levocabastine are effective  
in conjunction with INCS and oral  
antihistamines for ocular symptoms.  
Leukotriene receptor antagonist 
The leukotriene receptor antagonists (LRA)  
montelukast should not be used as first- 
line treatment for allergic rhinitis.  It is less  
31 
effective than intranasal corticosteroids,  
and possibly comparable to oral  
antihistamines.  In combination with an  
22 
oral antihistamine, LRAs are more effective  
than oral antihistamine alone.    
22 
Montelukast may be beneficial in  
concomitant seasonal allergic rhinitis  
and asthma, especially exercise-induced  
bronchoconstriction or aspirin exacerbated  
respiratory disease.  It has been found  
32 
to improve nasal and bronchial symptoms  
with a reduction of reliever use.    
5 
Anticholinergics 
Intranasal anticholinergics such as  
ipratropium bromide may be effective  
in controlling watery rhinorrhoea, but  
are ineffective against sneezing and  
nasal congestion.    
4 
Cromones 
Mast cell stabilisers such as sodium  
cromoglycate play only a minor role in  
the treatment of allergic rhinitis. Sodium  
cromoglycate must be used four times  
a day and has relatively small effects on  
nasal symptoms when compared with  
antihistamines and INCS. 
Decongestants  
Oral and intranasal decongestants  
may be used in cases of severe nasal  
blockage for a few days. However,  
they have no effect on other symptoms  
of allergic rhinitis. Prolonged use of  
topical decongestants for more than five  
days may cause rebound congestion  
(rhinitis medicamentosa). 
Combination of an oral decongestant  
and antihistamine provides decongestant  
efficacy superior to that of either  
drug alone. 
33 
Immunotherapy 
Allergen specific immunotherapy should  
be considered for patients with moderate  
or severe persistent allergic rhinitis that is  
not responsive to usual treatments. Patients  
are desensitised by receiving increasing  
doses of allergen either in injections as  
subcutaneous immunotherapy or in tablets  
and drops as sublingual immunotherapy.  
TO PAGE 80 
Medicine class   
Itch/sneeze 
Nasal discharge  
Nasal blockage  
Eye symptoms  
Intranasal  
corticosteroids 
+++ 
+++ 
++ 
++ 
Oral/intranasal  
antihistamines 
++ 
++ 
+/- 
++ (oral)  
- (intranasal) 
Oral/intranasal  
decongestants 
- 
- 
+ (oral)  
+++ (intranasal) 
Cromoglycate 
+ 
+ 
+/- 
- 
Ipratropium 
- 
+++ 
- 
- 
Montelukast 
- 
+ 
++ 
++ 
Table 1. 
 Symptomatic treatment of allergic rhinitis in adults. 
20 
Medicine class  
Active ingredient  
Trade names  
Daily maintenance dose  
Intranasal  
corticosteroids (INCS) 
Beclomethasone  
dipropionate 
Beconase Allergy &  
Hayfever 12 Hour 
two sprays twice daily. 
Budesonide 
Rhinocort Hayfever,  
Rhinocort, Budamax 
One or two sprays once  
daily. 
Ciclesonide 
Omnaris 
two sprays once daily. 
Fluticasone propionate 
Flixonase Nasule Drops,  
Flixonase Allergy &  
Hayfever 24 Hour 
one spray once daily. 
Fluticasone furoate 
Avamys 
one spray once daily. 
Mometasone furoate 
Nasonex Allergy  
Aqueous Nasal Spray,  
Metaspray, Sensease  
Nasal Allergy Relief  
Nasal Spray, Azonaire  
Hayfever & Allergy  
Prevention & Relief  
Nasal Spray 
one spray once daily. 
Intranasal corticosteroid  
/antihistamine 
Fluticasone propionate/ 
azelastine 
Dymista 
one spray twice daily. 
Intranasal antihistamines 
Azelastine 
Azep 
one spray twice daily. 
Levocabastine 
Livostin, Zyrtec  
Levocabastine 
two sprays twice daily. 
Oral less-sedating  
antihistamines 
Cetirizine 
Zyrtec, Alzene, Zilarex 
one daily. 
Desloratadine 
Aerius 
one daily. 
Fexofenadine 
Telfast, Amcal Fexo,  
Fexotabs, Tefodine,  
Xergic 
one daily. 
Loratadine 
Claratyne, Allereze,  
Lorano 
one daily. 
Intranasal  
anticholinergics 
Ipratropium 
Atrovent Nasal, Atrovent  
Nasal Forte 
two to three times daily. 
Cromones 
Sodium cromoglycate 
Rynacrom Metered  
Dose Nasal Spray 
one spray four times  
daily. 
Leukotriene receptor  
antagonists 
Montelukast 
Singulair, Lukair,  
Montelair, Respikast 
10mg daily. 
Table 2. 
 Medicines for treatment of allergic rhinitis in adults. 
+++ very effective, ++ moderately effective, + marginally effective, +/- little or no effect, - ineffective
   79   80   81   82   83